Martingale Asset Management L P Has $14.55 Million Stake in Encompass Health Co. (NYSE:EHC)

Martingale Asset Management L P decreased its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 10.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 157,585 shares of the company's stock after selling 18,524 shares during the quarter. Martingale Asset Management L P owned approximately 0.16% of Encompass Health worth $14,553,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its holdings in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares in the last quarter. CBIZ Investment Advisory Services LLC raised its position in Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new stake in Encompass Health in the fourth quarter valued at $46,000. V Square Quantitative Management LLC increased its stake in shares of Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares during the last quarter. Finally, Signaturefd LLC raised its holdings in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after purchasing an additional 125 shares during the period. Institutional investors own 97.25% of the company's stock.

Remove Ads

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.10% of the stock is currently owned by company insiders.

Encompass Health Price Performance

EHC traded up $0.63 on Monday, hitting $102.80. 281,655 shares of the stock were exchanged, compared to its average volume of 726,721. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The firm has a market capitalization of $10.35 billion, a price-to-earnings ratio of 23.05, a PEG ratio of 2.31 and a beta of 0.87. The business has a 50-day moving average of $99.56 and a two-hundred day moving average of $98.03. Encompass Health Co. has a 12 month low of $78.53 and a 12 month high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Sell-side analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's payout ratio is 15.25%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. StockNews.com cut shares of Encompass Health from a "buy" rating to a "hold" rating in a report on Thursday, April 3rd. Barclays boosted their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. KeyCorp lifted their price target on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Finally, William Blair restated an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health currently has an average rating of "Buy" and a consensus target price of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.